Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience

Superinfections with Aspergillus spp. in patients with Coronavirus disease 2019 (CAPA: COVID-19-associated pulmonary aspergillosis) are increasing. Dexamethasone has shown beneficial effects in critically ill COVID-19 patients. Whether dexamethasone increases the risk of CAPA has not been studied ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubler, Simon, Turan, Ömer Can, Schmidt, Karsten Daniel, rath, Peter-michael, Verhasselt, Hedda-Luise, Maier, Sandra, Skarabis, Annabell, Brenner, Thorsten, Herbstreit, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777363/
https://www.ncbi.nlm.nih.gov/pubmed/36553055
http://dx.doi.org/10.3390/diagnostics12123049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777363/
https://www.ncbi.nlm.nih.gov/pubmed/36553055
http://dx.doi.org/10.3390/diagnostics12123049

Ejemplares similares